According to Endocrinology Advisor, more than one-third of all doctors are now suggesting mobile apps to their patients. It is also expected that in the coming years, mobile applications will play a larger role in assisting doctors with both diagnosing and treating their patients.
For the time being, no app is the clear front runner among various physician favorites. In fact, many doctors are unsure of which apps to direct their patients to. This is due in part to the fact that there are currently over 40,000 mHealth apps to choose from and more being developed every day. On top of that, few apps that have FDA approval.
In order for the number of apps to receive FDA approval to climb, more clinical trials will need to be performed, both for the advantage of mobile apps in general, as well as clinical trials for individual apps. These clinical trials will need to be more than just patient-centered, but also easy for doctors to read, receive, and analyze the data gathered.